Results of a recent three-year follow-up study, conducted by the Centre for Myopia Research at The Hong Kong Polytechnic University and published in March 2021 in the British Journal of Ophthalmology, showed that slowing down the progression of myopia over time was sustained in the group of children wearing MiYOSMART spectacle lens with D.I.M.S. Technology3.
Dr. Paul Gifford and Dr. Kate Gifford, founders of Myopia Profile, said “we are pleased to have collaborated with HOYA Vision Care in their project to bring comprehensive educational support to ECP’s engaging in myopia management and prescribing the groundbreaking MiYOSMART spectacle lens. Evidence-based, responsible clinical communication and prescribing for myopic children are of utmost importance. Myopia Profile’s work in laying the foundation on myopia consequences, interventions and clinical approaches sits alongside HOYA Vision Care’s training on MiYOSMART to provide a thorough base for ECP’s seeking to make a difference in the progression of childhood myopia across the world.”
PRODUCT DISCLAIMER – MiYOSMART has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S.
1 Holden B. A. et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123(5):1036-1042
2Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739
3 Lam CS, Tang WC, Lee PH, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology Published Online First: 17 March 2021. doi: 10.1136/bjophthalmol-2020-317664